Found: 28
Select item for more details and to access through your institution.
Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome.
- Published in:
- BJU International, 2009, v. 104, n. 10, p. 1467, doi. 10.1111/j.1464-410X.2009.08575.x
- By:
- Publication type:
- Article
Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis.
- Published in:
- BJU International, 2008, v. 101, n. 10, p. 1302, doi. 10.1111/j.1464-410X.2008.07514.x
- By:
- Publication type:
- Article
Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 6, p. e401, doi. 10.1016/j.clgc.2021.08.007
- By:
- Publication type:
- Article
Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 3, p. 801, doi. 10.1245/s10434-017-6297-1
- By:
- Publication type:
- Article
PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer.
- Published in:
- Journal of Pathology, 2009, v. 218, n. 4, p. 505, doi. 10.1002/path.2559
- By:
- Publication type:
- Article
Mitosis Phase Enrichment with Identification of Mitotic Centromere-Associated Kinesin As a Therapeutic Target in Castration-Resistant Prostate Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031259
- By:
- Publication type:
- Article
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2170, doi. 10.3390/cancers13092170
- By:
- Publication type:
- Article
Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.
- Published in:
- European Journal of Endocrinology, 2013, v. 169, n. 6, p. 891, doi. 10.1530/EJE-13-0519
- By:
- Publication type:
- Article
Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study.
- Published in:
- World Journal of Surgical Oncology, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1477-7819-11-298
- By:
- Publication type:
- Article
Role of Repeated Biopsy of the Prostate in Predicting Disease Progression in Patients With Prostate Cancer on Active Surveillance.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 2, p. 286, doi. 10.1002/cncr.23575
- By:
- Publication type:
- Article
Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Up‐regulation of Wnt‐1 and β‐catenin production in patients with advanced metastatic prostate carcinoma: Potential pathogenetic and prognostic implications.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 6, p. 1345, doi. 10.1002/cncr.20518
- By:
- Publication type:
- Article
Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer.
- Published in:
- Histopathology, 2012, v. 60, n. 4, p. 645, doi. 10.1111/j.1365-2559.2011.04116.x
- By:
- Publication type:
- Article
Uc.416 + A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Banking of fresh-frozen prostate tissue using the alternate mirror image protocol: methods, validation, and impact on the pathological prognostic parameters in radical prostatectomy.
- Published in:
- Cell & Tissue Banking, 2012, v. 13, n. 4, p. 631, doi. 10.1007/s10561-011-9284-y
- By:
- Publication type:
- Article
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.
- Published in:
- BJU International, 2017, v. 120, n. 6, p. 782, doi. 10.1111/bju.13705
- By:
- Publication type:
- Article
Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases.
- Published in:
- BJU International, 2016, v. 117, n. 5, p. 761, doi. 10.1111/bju.13185
- By:
- Publication type:
- Article
BCG for Upper-Tract Transitional-Cell Carcinoma: Is It Safe in Patients with Renal Compromise?
- Published in:
- Journal of Endourology, 2006, v. 20, n. 12, p. 1068, doi. 10.1089/end.2006.20.1068
- By:
- Publication type:
- Article
Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis.
- Published in:
- Endocrine (1355008X), 2016, v. 51, n. 2, p. 351, doi. 10.1007/s12020-015-0694-7
- By:
- Publication type:
- Article
PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications.
- Published in:
- Genes, Chromosomes & Cancer, 2012, v. 51, n. 2, p. 149, doi. 10.1002/gcc.20939
- By:
- Publication type:
- Article
Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non‐sarcomatoid renal carcinomas.
- Published in:
- Journal of Pathology: Clinical Research, 2015, v. 1, n. 4, p. 212, doi. 10.1002/cjp2.23
- By:
- Publication type:
- Article
Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Mammalian Target of Rapamycin Pathway Is Widely Activated Without PTEN Deletion in Renal Cell Carcinoma Metastases.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 2, p. 290, doi. 10.1002/cncr.25402
- By:
- Publication type:
- Article
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. 392, doi. 10.1093/oncolo/oyad302
- By:
- Publication type:
- Article
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas.
- Published in:
- Oncologist, 2023, v. 28, n. 5, p. 433, doi. 10.1093/oncolo/oyac262
- By:
- Publication type:
- Article
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 641, p. 1, doi. 10.1126/scitranslmed.abm6420
- By:
- Publication type:
- Article
Enhancer of Zeste Homolog 2 Expression Is Associated With Metastasis and Adverse Clinical Outcome in Clear Cell Renal Cell Carcinoma.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2013, v. 137, n. 10, p. 1326, doi. 10.5858/arpa.2012-0525-OA
- By:
- Publication type:
- Article
Prioritizing genes associated with prostate cancer development.
- Published in:
- BMC Cancer, 2010, v. 10, p. 599, doi. 10.1186/1471-2407-10-599
- By:
- Publication type:
- Article